Literature DB >> 26237449

CSN6 positively regulates c-Jun in a MEKK1-dependent manner.

Jihyun Shin1, Liem Phan1, Jian Chen1, Zhimin Lu2, Mong-Hong Lee1.   

Abstract

c-Jun is a proto-oncoprotein that is commonly overexpressed in many types of cancer and is believed to regulate cell proliferation, the cell cycle, and apoptosis by controlling AP-1 activity. Understanding the c-Jun regulation is important to develop treatment strategy for cancer. The COP9 signalosome subunit 6 (CSN6) plays a critical role in ubiquitin-mediated protein degradation. MEKK1 is a serine/threonine kinase and E3 ligase containing PHD/RING domain involved in c-Jun ubiquitination. Here, we show that CSN6 associates with MEKK1 and reduces MEKK1 expression level by facilitating the ubiquitin-mediated degradation of MEKK1. Also we show that CSN6 overexpression diminishes MEKK1-mediated c-Jun ubiquitination, which is manifested in mitigating osmotic stress-mediated c-Jun downregulation. Thus, CSN6 is involved in positively regulating the stability of c-Jun. Overexpression of CSN6 correlates with the upregulation of c-Jun target gene expression in cancer. These findings provide new insight into CSN6-MEKK1-c-Jun axis in tumorigenesis.

Entities:  

Keywords:  COP9 signalosome; CSN6; MEKK1; c-Jun

Mesh:

Substances:

Year:  2015        PMID: 26237449      PMCID: PMC4825627          DOI: 10.1080/15384101.2015.1078030

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  53 in total

1.  Aberrant expression of c-Jun in glioblastoma by internal ribosome entry site (IRES)-mediated translational activation.

Authors:  Lior Blau; Revital Knirsh; Iris Ben-Dror; Sivan Oren; Silke Kuphal; Peter Hau; Martin Proescholdt; Anja-Katrin Bosserhoff; Lily Vardimon
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-01       Impact factor: 11.205

2.  Role of TAZ as mediator of Wnt signaling.

Authors:  Luca Azzolin; Francesca Zanconato; Silvia Bresolin; Mattia Forcato; Giuseppe Basso; Silvio Bicciato; Michelangelo Cordenonsi; Stefano Piccolo
Journal:  Cell       Date:  2012-12-13       Impact factor: 41.582

3.  Expression of Jun family members in human colorectal adenocarcinoma.

Authors:  H Wang; M Birkenbach; J Hart
Journal:  Carcinogenesis       Date:  2000-07       Impact factor: 4.944

4.  MEKK1 binds raf-1 and the ERK2 cascade components.

Authors:  M Karandikar; S Xu; M H Cobb
Journal:  J Biol Chem       Date:  2000-12-22       Impact factor: 5.157

5.  Roles for CSN5 in control of p53/MDM2 activities.

Authors:  Xiao-Chun Zhang; Jian Chen; Chun-Hui Su; Heng-Yin Yang; Mong-Hong Lee
Journal:  J Cell Biochem       Date:  2008-03-01       Impact factor: 4.429

6.  Promoter specificity and biological activity of tethered AP-1 dimers.

Authors:  Latifa Bakiri; Koichi Matsuo; Marta Wisniewska; Erwin F Wagner; Moshe Yaniv
Journal:  Mol Cell Biol       Date:  2002-07       Impact factor: 4.272

7.  Casein kinase II is a negative regulator of c-Jun DNA binding and AP-1 activity.

Authors:  A Lin; J Frost; T Deng; T Smeal; N al-Alawi; U Kikkawa; T Hunter; D Brenner; M Karin
Journal:  Cell       Date:  1992-09-04       Impact factor: 41.582

8.  JNK2 is a positive regulator of the cJun transcription factor.

Authors:  Anja Jaeschke; Maria Karasarides; Juan-Jose Ventura; Anka Ehrhardt; Chao Zhang; Richard A Flavell; Kevan M Shokat; Roger J Davis
Journal:  Mol Cell       Date:  2006-09-15       Impact factor: 17.970

9.  The cell cycle regulator 14-3-3σ opposes and reverses cancer metabolic reprogramming.

Authors:  Liem Phan; Ping-Chieh Chou; Guermarie Velazquez-Torres; Ismael Samudio; Kenneth Parreno; Yaling Huang; Chieh Tseng; Thuy Vu; Chris Gully; Chun-Hui Su; Edward Wang; Jian Chen; Hyun-Ho Choi; Enrique Fuentes-Mattei; Ji-Hyun Shin; Christine Shiang; Brian Grabiner; Marzenna Blonska; Stephen Skerl; Yiping Shao; Dianna Cody; Jorge Delacerda; Charles Kingsley; Douglas Webb; Colin Carlock; Zhongguo Zhou; Yun-Chih Hsieh; Jaehyuk Lee; Andrew Elliott; Marc Ramirez; Jim Bankson; John Hazle; Yongxing Wang; Lei Li; Shaofan Weng; Nibal Rizk; Yu Ye Wen; Xin Lin; Hua Wang; Huamin Wang; Aijun Zhang; Xuefeng Xia; Yun Wu; Mouhammed Habra; Wei Yang; Lajos Pusztai; Sai-Ching Yeung; Mong-Hong Lee
Journal:  Nat Commun       Date:  2015-07-16       Impact factor: 14.919

10.  Effects of obesity on transcriptomic changes and cancer hallmarks in estrogen receptor-positive breast cancer.

Authors:  Enrique Fuentes-Mattei; Guermarie Velazquez-Torres; Liem Phan; Fanmao Zhang; Ping-Chieh Chou; Ji-Hyun Shin; Hyun Ho Choi; Jiun-Sheng Chen; Ruiying Zhao; Jian Chen; Chris Gully; Colin Carlock; Yuan Qi; Ya Zhang; Yun Wu; Francisco J Esteva; Yongde Luo; Wallace L McKeehan; Joe Ensor; Gabriel N Hortobagyi; Lajos Pusztai; W Fraser Symmans; Mong-Hong Lee; Sai-Ching Jim Yeung
Journal:  J Natl Cancer Inst       Date:  2014-06-23       Impact factor: 13.506

View more
  9 in total

Review 1.  CSN6: a promising target for cancer prevention and therapy.

Authors:  Jianbing Hou; Hongjuan Cui
Journal:  Histol Histopathol       Date:  2020-02-04       Impact factor: 2.303

2.  CSN6 expression is associated with pancreatic cancer progression and predicts poor prognosis.

Authors:  Jiaqi Shi; Xin Guan; Fei Zhan; Chao Liu; Zhiwei Li; Yuanfei Yao; Bojun Wang; Changjie Lou; Yanqiao Zhang
Journal:  Cancer Biol Ther       Date:  2019-07-16       Impact factor: 4.742

3.  COP9 signalosome subunit CSN5, but not CSN6, is upregulated in lung adenocarcinoma and predicts poor prognosis.

Authors:  Dakai Xiao; Shengli Yang; Liyan Huang; Huiming He; Hui Pan; Jianxing He
Journal:  J Thorac Dis       Date:  2018-03       Impact factor: 2.895

4.  COP9 signalosome subunit 6 (CSN6) regulates E6AP/UBE3A in cervical cancer.

Authors:  Shujun Gao; Lekun Fang; Liem Minh Phan; Aiham Qdaisat; Sai-Ching J Yeung; Mong-Hong Lee
Journal:  Oncotarget       Date:  2015-09-29

5.  CSN6 Promotes the Migration and Invasion of Cervical Cancer Cells by Inhibiting Autophagic Degradation of Cathepsin L.

Authors:  Zun Mao; Miao-Miao Sang; Cheng Chen; Wen-Tao Zhu; Yu-Sen Gong; Dong-Sheng Pei
Journal:  Int J Biol Sci       Date:  2019-05-12       Impact factor: 6.580

6.  CSN6 promotes tumorigenesis of gastric cancer by ubiquitin-independent proteasomal degradation of p16INK4a.

Authors:  Wenqi Du; Zongxiang Liu; Wentao Zhu; Tongtong Li; Zhiman Zhu; Lulu Wei; Jun Song; Dongsheng Pei
Journal:  Cancer Biol Med       Date:  2019-08       Impact factor: 4.248

7.  CSN6 promotes the cell migration of breast cancer cells by positively regulating Snail1 stability.

Authors:  Jie Mou; Lulu Wei; Jia Liang; Wenqi Du; Dongsheng Pei
Journal:  Int J Med Sci       Date:  2020-10-01       Impact factor: 3.738

8.  CSN6 promotes melanoma proliferation and metastasis by controlling the UBR5-mediated ubiquitination and degradation of CDK9.

Authors:  Yanli Zhang; Jianbing Hou; Shaomin Shi; Juan Du; Yudong Liu; Pan Huang; Qian Li; Lichao Liu; Huanrong Hu; Yacong Ji; Leiyang Guo; Yaqiong Shi; Yaling Liu; Hongjuan Cui
Journal:  Cell Death Dis       Date:  2021-01-22       Impact factor: 8.469

9.  MEKK1-Dependent Activation of the CRL4 Complex Is Important for DNA Damage-Induced Degradation of p21 and DDB2 and Cell Survival.

Authors:  Susanne Bacher; Hilda Stekman; Carla M Farah; Annika Karger; Michael Kracht; M Lienhard Schmitz
Journal:  Mol Cell Biol       Date:  2021-07-12       Impact factor: 4.272

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.